Join
Live feed
·
INSIDERFilingvia Quantisnow
CRISPR Therapeutics AG logo

Chief Financial Officer Prasad Raju sold $476,278 worth of shares (9,869 units at $48.26), gifted 750 shares and converted options into 16,875 shares, increasing direct ownership by 92% to 13,023 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRSP (CRISPR Therapeutics AG) and more on Quantisnow.